Heart Decompensation
29
2
2
14
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.8%
4 terminated out of 29 trials
77.8%
-8.7% vs benchmark
14%
4 trials in Phase 3/4
14%
2 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (29)
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
RAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure Rehospitalization
Big Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Heart Failure
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
Interest of the Smartphone Application "MonCœur" in the Follow-up of Patients With Heart Failure
Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF
Study of the Sudden Heart Failure Participant Population in the US
Comparison of PEEP in Acute Decompensated Heart Failure
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
Skeletal Muscles in Acute Heart Failure
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
Pronostic Value of Endothelial Dysfunction in Heart Failure
Treating Congestive Heart Failure Using a Device to Remove Cholesterol
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients